¡@¡@Although the Bio-pharmaceutical industry in Taiwan is less then 1% in worldwide medical market¡CAlmost 150 Bio-pharmaceutical companies in Taiwan were met the cGMP standard, yet limited on the R&D human resources and the capital size ¡Amost of the companies all focus on the manufacturing of Generic products.
¡@¡@As the Internationalize and Globalize were mainstreams for all Pharmaceutical industries. We need to take this into consideration that how we increase Taiwan¡¦s competitiveness, and win out over the other industry in the international alliance. And should we improve any weakness? Efficiency, Inventory, or customer needs?¡@¡@
¡@¡@So far¡Mbecause of the conflict of the Regulation requirements¡M. Most Bio-industry was not using the ERP/SCM for the management¡C In this study¡MWe hope to provide an actual example for the other Bio-industry as reference¡Mand then as an application model to improve the competitiveness of Taiwan Bio-pharmaceutical industry.¡@¡@
¡@¡@During the dissertation, we discover the monograph rational of ERP/SCM, and consider the regulation limited when follow the SCM model to analyze the process suitability and performance for Bio-pharmaceutical Company.
¡@¡@As result, we know that the ERP/MRP-II system or Supply chain management was necessary to the Bio-pharmaceutical industry.
| Identifer | oai:union.ndltd.org:NSYSU/oai:NSYSU:etd-0804104-055420 |
| Date | 04 August 2004 |
| Creators | Chen, Yung-Yi |
| Contributors | Bih-Shiaw Jaw, Yueh H. Chen, Iuan-Yuan Lu, Hsien-Tang Tsai |
| Publisher | NSYSU |
| Source Sets | NSYSU Electronic Thesis and Dissertation Archive |
| Language | Cholon |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0804104-055420 |
| Rights | unrestricted, Copyright information available at source archive |
Page generated in 2.0276 seconds